The latest progress in research on triple negative breast cancer (TNBC): risk factors, possible therapeutic targets and prognostic markers

Triple negative breast cancer (TNBC) is one type of breast cancer (BC), which is defined as negative for estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-2 (Her2). Its origins and development seem to be elusive. And for now, drugs like tamoxifen or trastu...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Jiao, Qingli, Wu, Aiguo, Shao, Guoli, Peng, Haoyu, Wang, Mengchuan, Ji, Shufeng, Liu, Peng, Zhang, Jian
Формат: Artigo
Язык:Inglês
Опубликовано: Pioneer Bioscience Publishing Company 2014
Предметы:
Review Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4178098/
https://ncbi.nlm.nih.gov/pubmed/25276378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2014.08.13
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы